Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-043510
Filing Date
2022-07-29
Accepted
2022-07-29 16:18:14
Documents
1
Period of Report
2022-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3405
  Complete submission text file 0001209191-22-043510.txt   4973
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Issuer) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address
TOMBESI PAOLO (Reporting) CIK: 0001707648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38871 | Film No.: 221121042